Literature DB >> 34083786

Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB.

Roy Maimon1,2, Carlos Chillon-Marinas1,2, Cedric E Snethlage3, Sarthak M Singhal4, Melissa McAlonis-Downes1,2, Karen Ling5, Frank Rigo5, C Frank Bennett5, Sandrine Da Cruz1,6, Thomas S Hnasko4,7, Alysson R Muotri2,3, Don W Cleveland8,9.   

Abstract

Methods to enhance adult neurogenesis by reprogramming glial cells into neurons enable production of new neurons in the adult nervous system. Development of therapeutically viable approaches to induce new neurons is now required to bring this concept to clinical application. Here, we successfully generate new neurons in the cortex and dentate gyrus of the aged adult mouse brain by transiently suppressing polypyrimidine tract binding protein 1 using an antisense oligonucleotide delivered by a single injection into cerebral spinal fluid. Radial glial-like cells and other GFAP-expressing cells convert into new neurons that, over a 2-month period, acquire mature neuronal character in a process mimicking normal neuronal maturation. The new neurons functionally integrate into endogenous circuits and modify mouse behavior. Thus, generation of new neurons in the dentate gyrus of the aging brain can be achieved with a therapeutically feasible approach, thereby opening prospects for production of neurons to replace those lost to neurodegenerative disease.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34083786      PMCID: PMC8338913          DOI: 10.1038/s41593-021-00864-y

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  46 in total

1.  Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.

Authors:  F Doetsch; I Caillé; D A Lim; J M García-Verdugo; A Alvarez-Buylla
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

2.  Astroglia induce neurogenesis from adult neural stem cells.

Authors:  Hongjun Song; Charles F Stevens; Fred H Gage
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

3.  Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

Authors:  Holly B Kordasiewicz; Lisa M Stanek; Edward V Wancewicz; Curt Mazur; Melissa M McAlonis; Kimberly A Pytel; Jonathan W Artates; Andreas Weiss; Seng H Cheng; Lamya S Shihabuddin; Gene Hung; C Frank Bennett; Don W Cleveland
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

Review 4.  Neurogenesis in the Adult Hippocampus.

Authors:  Gerd Kempermann; Hongjun Song; Fred H Gage
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-01       Impact factor: 10.005

5.  An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.

Authors:  Timothy M Miller; Alan Pestronk; William David; Jeffrey Rothstein; Ericka Simpson; Stanley H Appel; Patricia L Andres; Katy Mahoney; Peggy Allred; Katie Alexander; Lyle W Ostrow; David Schoenfeld; Eric A Macklin; Daniel A Norris; Georgios Manousakis; Matthew Crisp; Richard Smith; C Frank Bennett; Kathie M Bishop; Merit E Cudkowicz
Journal:  Lancet Neurol       Date:  2013-03-29       Impact factor: 44.182

6.  Astrocyte Depletion Impairs Redox Homeostasis and Triggers Neuronal Loss in the Adult CNS.

Authors:  Bettina Schreiner; Elisa Romanelli; Pawel Liberski; Barbara Ingold-Heppner; Bettina Sobottka-Brillout; Tom Hartwig; Vijay Chandrasekar; Helge Johannssen; Hanns Ulrich Zeilhofer; Adriano Aguzzi; Frank Heppner; Martin Kerschensteiner; Burkhard Becher
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

7.  Antisense oligonucleotides for neurodegeneration.

Authors:  Blair R Leavitt; Sarah J Tabrizi
Journal:  Science       Date:  2020-03-27       Impact factor: 47.728

8.  Newborn granule cells in the ageing dentate gyrus.

Authors:  Nicolás A Morgenstern; Gabriela Lombardi; Alejandro F Schinder
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

Review 9.  Current understanding of adult neurogenesis in the mammalian brain: how does adult neurogenesis decrease with age?

Authors:  Yoshitaka Kase; Takuya Shimazaki; Hideyuki Okano
Journal:  Inflamm Regen       Date:  2020-06-18

10.  Reversing a model of Parkinson's disease with in situ converted nigral neurons.

Authors:  Hao Qian; Xinjiang Kang; Jing Hu; Dongyang Zhang; Zhengyu Liang; Fan Meng; Xuan Zhang; Yuanchao Xue; Roy Maimon; Steven F Dowdy; Neal K Devaraj; Zhuan Zhou; William C Mobley; Don W Cleveland; Xiang-Dong Fu
Journal:  Nature       Date:  2020-06-24       Impact factor: 49.962

View more
  8 in total

1.  Limited astrocyte-to-neuron conversion in the mouse brain using NeuroD1 overexpression.

Authors:  David Leib; Yong Hong Chen; Alex Mas Monteys; Beverly L Davidson
Journal:  Mol Ther       Date:  2022-02-04       Impact factor: 11.454

2.  Fission Impossible: Stabilized miRNA-Based Analogs in Neurodegenerative Disease.

Authors:  Walter J Lukiw
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

Review 3.  In vivo glia-to-neuron conversion: pitfalls and solutions.

Authors:  Lei-Lei Wang; Chun-Li Zhang
Journal:  Dev Neurobiol       Date:  2022-05-23       Impact factor: 3.102

Review 4.  Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases.

Authors:  Matilde Contardo; Roberta De Gioia; Delia Gagliardi; Giacomo Pietro Comi; Linda Ottoboni; Monica Nizzardo; Stefania Corti
Journal:  Biomedicines       Date:  2022-02-07

5.  Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Weizhao Chen; Qiongping Zheng; Qiaoying Huang; Shanshan Ma; Mingtao Li
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

Review 6.  The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.

Authors:  Hannah Walgrave; Lujia Zhou; Bart De Strooper; Evgenia Salta
Journal:  Mol Neurodegener       Date:  2021-11-06       Impact factor: 14.195

Review 7.  Hippocampal neurogenesis and pro-neurogenic therapies for Alzheimer's disease.

Authors:  Jie Zheng
Journal:  Animal Model Exp Med       Date:  2022-02-06

8.  Knockdown of polypyrimidine tract binding protein facilitates motor function recovery after spinal cord injury.

Authors:  Ri-Yun Yang; Rui Chai; Jing-Ying Pan; Jing-Yin Bao; Pan-Hui Xia; Yan-Kai Wang; Ying Chen; Yi Li; Jian Wu; Gang Chen
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.